Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma

Journal of Clinical Pathology

Volumn 60, Issue 9, 2007, Pages 995-1000

  Soares, A B ^a   Ponchio, L ^b   Juliano, P B ^a   Araujo V C ^c   Altemani, Albina ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2 42; MONOCLONAL ANTIBODY KI 67; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CARCINOGENESIS; CARCINOMA; CARCINOMA CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; MYOEPITHELIUM CELL; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; SALIVARY GLAND; TUMOR ASSOCIATED LEUKOCYTE; TUMOR EMBOLISM; TUMOR GROWTH;

ADENOMA, PLEOMORPHIC; AGED; ANTIBODIES, MONOCLONAL; DISEASE PROGRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548855048     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.042523     Document Type: Article

References (39)

1. Barnes L, Everson JW, Reichart P, et al. World Organization Classification of Tumors. Pathology & genetics head and neck tumours. Lyon: IARC Press, 2005.
2. Santos IRB, Kowaslski LP, Araújo VC, et al. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 2001; 127:56-60.
3. Livolsi VA. Perzin KH. Malignant mixed tumors arising in salivary glands. Carcinomas arising in benign mixed tumors: a clinicopathologic study, Cancer 1977;39:2209-30.
4. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu 1993;28:279-328.
5. Ellis GL, Auclair PL. Malignant epithelial tumors. In: Rosai J, Sobin LH, eds. Atlas of tumor pathology, Series 3, Section 5, Fascicle 17. Washington, DC: Armed Forces Institute of Pathology, 1996:155-373.
6. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
7. Williams CS, Leek RD, Robson AM, et al. Absence of lymphangiogenesis and intratumoral lymph vessels in human metastatic breast cancer. J Pathol 2003;200:195-206.
8. Ji RC. Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histol Histopathol 2005;20:144-75.
9. Dadras SS, Paul T, Bertoncini J, Brown LF, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003;162:1951-60.
10. Kyzas PA, Geleff S, Batistatou A, et al. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005;206:170-7.
11. Gombos Z, Xu X, Chu CS, et al. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2005;11:8364-71.
12. Schoppmann SF, Horvat R, Birner P. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies. Oncol Rep 2002;9:455-60.
13. Koukourakis MI, Giatromanolaki A, Sivrides E, et al. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005;58:202-6.
14. Schmid K, Birner P, Gravenhorst V, et al. Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am J Surg Pathol 2005;29:324-8.
15. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001;7:462-8.
16. Clarijs R, Ruiter DJ, de Waal RM. Lymphangiogenesis in malignant tumours: does it occur? J Pathol 2001;193:143-6.
17. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002;62:1315-20.
18. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003;9:250-6.
19. Agarwal B, Saxena R, Morimiya A, et al. Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 2005;29:1449-55.
20. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumoral lymphatics. Science 2002;296:1883-6.
21. Schoppman SF, Bayer G, Aumayr K, et al. Australian breast and colorectal cancer study group. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Am Surg 2004;240:306-12.
22. Evangelou E, Kyzas PA, Trikalinos TA. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 2005;18:1490-7.
23. Schacht V, Dadras SS, Johnson L, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005;166:913-21.
24. Dumoff KL, Chu C, Xu X, et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol 2005;18:97-104.
25. Sabattini E, Bisgaard K, Ascani S, et al. The EnVision C system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, Chem-Mate, CSA, LABC and SABC techniques. J Clin Pathol 1998;51:506-11.
26. Franchi A, Gallo O, Massi D, et al. Tumor lymphangiogenesis in head and neck squamous cell carcinoma. Cancer 2004;101:973-8.
27. Gnepp DR, Brandwein MS, Henley JD. Salivary and lacrimal glands. In: Gnepp DR, eds. Diagnostic surgical pathology of the head and neck. Philadelphia: WB Saunders, 2000:325-430.
28. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 2001;32:596-604.
29. Brandwein M, Huvos AG, Dardick I, et al. Noninvasive and minimally invasive carcinoma ex mixed tumor. A clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:655-64.
30. Felix A, Rosa-Santos J, Mendonça ME, et al. Intracapsular carcinoma ex pleomorphic adenoma. Report of a case with unusual metastatic behaviour. Oral Oncol 2002;38:107-10.
31. Vleugel MM, Bos R, van der Groep P, et al. Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol 2004;57:746-51.
32. Salven P, Lymboussaki A, Heikkila P, et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998;153:103-8.
33. Partanen TA, Alitalo K, Mieltinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999;86:2406-12.
34. Giorgarize TA, Zhang PJ, Pasha T, et al. Lymphatic vessel density is significantly increased in melanoma. J Cutan Pathol 2004;31:672-7.
35. Maula SM, Luukkaa M, Grenman R, et al. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003;63:1920-6.
36. Altemani A, Martins MT, Freitas L, et al. Carcinoma ex pleomorphic adenoma (CXAP): immunoprofile of the cells involved in carcinomatous progression. Histopathology 2005;46:635-41.
37. Sternlich MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses 1997;48:37-46.
38. Ordóñez NG. Podoplanin: a novel diagnostic immunohistochemical marker. Adv Anal Pathol 2006;13:83-6.
39. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 1990;80:569-78.